Lumilens was last valued at $5.5B (post-money). It comes from the $700M Series C of Aug 2026. The company is private, so there is no listed share price.
1 valuation. The latest, $5.5B post-money, was set by the Series C in Aug 2026.
A private valuation is the price agreed in one transaction. The Lumilens valuation of $5.5B is a post-money figure from the Series C dated 6 Aug 2026 — the whole company measured after the $700M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $4.8B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2024 with roughly 108 people has no daily price and no order book between rounds.
The routes section explains what is realistically available for a company at this stage.
No. Lumilens is a private company; its shares do not trade on a public exchange.
The last valuation is $5.5B (post-money, Aug 2026).
The closest ai infrastructure / photonics peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
